Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharmaceut Sun Pharmaceutical Industries Ltd. | BSE 1717.00 -0.50 (-0.03%) | NSE 1717.10 -0.10 (-0.01%) | Trade | Add

BSE Live

Dec 30, 13:49

1717.00 -0.50 (-0.03%)

Volume

AVERAGE VOLUME

5-Day

116,510

10-Day

114,627

30-Day

82,032

31,833

Prev. Close

1717.50
Open Price

1717.15

Bid Price (Qty.)
1716.50 (20)
Offer Price (Qty.)
1717.20 (25)

NSE Live

Dec 30, 13:49

1717.10 -0.10 (-0.01%)

Volume

AVERAGE VOLUME

5-Day

1,825,010

10-Day

2,019,694

30-Day

2,004,958

1,103,825

Prev. Close

1717.20
Open Price

1723.10

Bid Price (Qty.)
1717.00 (115)
Offer Price (Qty.)
1717.10 (187)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	11,906.74	9,783.29	8,774.41	7,509.67	7,262.46
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	109.24	130.43
Revenue From Operations [Net]	11,906.74	9,783.29	8,774.41	7,400.43	7,132.03
Total Operating Revenues	12,531.93	10,303.21	9,006.25	7,683.96	7,614.46
Other Income	1,510.92	1,271.44	1,128.04	515.08	431.82
Total Revenue	14,042.85	11,574.65	10,134.29	8,199.04	8,046.28
EXPENSES
Cost Of Materials Consumed	3,201.71	2,727.71	2,210.12	2,228.45	2,019.85
Purchase Of Stock-In Trade	1,227.41	1,196.85	1,201.51	1,236.50	1,170.00
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	138.60	-251.30	159.26	-167.86	-68.48
Employee Benefit Expenses	1,702.77	1,571.34	1,625.00	1,499.88	1,480.51
Finance Costs	408.01	540.92	388.31	223.57	530.64
Depreciation And Amortisation Expenses	561.56	552.95	487.24	422.28	463.98
Other Expenses	3,549.79	3,302.35	2,832.10	2,773.02	3,447.56
Total Expenses	10,789.85	9,640.82	8,903.54	8,215.84	9,044.06
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	3,253.00	1,933.83	1,230.75	-16.80	-997.78
Exceptional Items	0.00	-1,214.38	-950.50	0.00	-70.13
Profit/Loss Before Tax	3,253.00	719.45	280.25	-16.80	-1,067.91
Tax Expenses-Continued Operations
Current Tax	386.46	1.55	2.02	5.77	5.45
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-344.60	-98.70	-27.41	0.27	0.00
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	41.86	-97.15	-25.39	6.04	5.45
Profit/Loss After Tax And Before ExtraOrdinary Items	3,211.14	816.60	305.64	-22.84	-1,073.36
Profit/Loss From Continuing Operations	3,211.14	816.60	305.64	-22.84	-1,073.36
Profit/Loss For The Period	3,211.14	816.60	305.64	-22.84	-1,073.36
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	13.40	3.40	1.30	-0.10	-4.50
Diluted EPS (Rs.)	13.40	3.40	1.30	-0.10	-4.50
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	823.35
Indigenous Raw Materials	0.00	0.00	0.00	0.00	1,196.50
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	77.34
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	283.04
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	1,378.96	479.16	797.74	240.68	240.68
Tax On Dividend	192.89	0.56	0.34	7.47	7.47
Equity Dividend Rate (%)	400.00	275.00	200.00	350.00	100.00